Hence then, the article about akeso announces first patient enrollment in phase 3 trial of ivonescimab combination as first line therapy for biliary tract tumors compared to durvalumab was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab )
Last updated :
Also on site :
- Five killed in helicopter crash on Africa’s highest mountain (VIDEO)
- transcosmos and V, Inc. launch metaverse creator services for VRChat via Geek Jack, transcosmos's cross-border e-commerce site for entertainment items
- The Christmas Day Storm